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Abstract: OCT has been demonstrated as an eﬃcient imaging modality in various biomed-
ical and clinical applications. However, there is a missing link with respect to the source of
contrast between OCT and other modern imaging modalities, no quantitative comparison has
been demonstrated between them, yet. We evaluated, to our knowledge, for the first time in
vivo OCT measurement of rat brain with our previously proposed forward imaging method
by both qualitatively and quantitatively correlating OCT with the corresponding T1-weighted
and T2-weighted magnetic resonance images, fiber density map (FDM), and two types of his-
tology staining (cresyl violet and acetylcholinesterase AchE), respectively. Brain anatomical
structures were identified and compared across OCT, MRI and histology imaging modalities.
Noticeable resemblances corresponding to certain anatomical structures were found between
OCT and other image profiles. Correlation was quantitatively assessed by estimating correlation
coeﬃcient (R) and mutual information (MI). Results show that the 1-D OCT measurements in
regards to the intensity profile and estimated attenuation factor, do not have profound linear
correlation with the other image modalities suggested from correlation coeﬃcient estimation.
However, findings in mutual information analysis demonstrate that there are markedly high MI
values in OCT-MRI signals.
c© 2016 Optical Society of America
OCIS codes: (170.170) Medical optics and biotechnology; (170.388) Medical and biological imaging; (170.450) Opti-
cal coherence tomography.
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1. Introduction
Optical coherence tomography (OCT) is a non-ionising optical imaging modality introduced
in the early 90’s [1, 2]. It utilises optical scattering properties of the tissue to generate an im-
age where the contrast comes from diﬀerences in the optical reflectivity and backscattering of
the tissue. Featuring a high imaging resolution of about 2 μm [3], and fast imaging speed up
to 10 millions axial scans per second [4], OCT has been demonstrated as an eﬃcient imaging
modality in various biomedical and clinical applications, such as retinal imaging for diagnostic
purpose [5, 6]. When integrated with a glass fiber catheter, it allows to perform minimally inva-
sive endoscopic interventions of inner organs [7–10]. In particular, the fiber-based OCT has the
potential to facilitate distinction of brain anatomical structures for real-time minimally-invasive
surgical guidance [9, 11].
The evaluation is often done by qualitatively comparing OCT images with the corresponding
tissue histology or an atlas [12–14]. There is a missing link between OCT and the other imag-
ing modalities such as magnetic resonance imaging (MRI) or computed tomography (CT) with
respect to the fundamental sources and relation of respective image contrast. Unglert et al. have
validated OCT measurements of alveolar size by correlating them with CT measurements quan-
titatively [15]. However, this validation process was conducted on formaldehyde fixed swine
lung specimens, thus both OCT and CT measurements were performed ex vivo. Gudmunds-
dottir et al. investigated the linear correlation between frequency domain optical coherence
tomography (FD-OCT) and intravascular ultrasound (IVUS) in patients with calcific coronary
artery disease [16]. The demand for quantitatively evaluation of in vivo OCT measurements by
correlating with other well-established imaging exists.
The goal of this study was to evaluate in vivo OCT measurement of rat brain with our pre-
viously proposed forward imaging method [9] by qualitatively and quantitatively correlating it
with the corresponding T1 and T2-weighted magnetic resonance images (MRI), fiber density
map (FDM), and two types of tissue staining (cresyl violet and acetylcholinesterase), respec-
tively [17–19]. Brain anatomical structures were distinguished in OCT measurements, and cor-
related between OCT, MRI and histology images. For quantification, we first used resampling to
equalize the sample length of all signals. Direct comparison were performed on the consolidated
signals to find any resemblances between image profiles. We used dynamic time warping (DTW)
to estimate the cost of align the two signals. Correlation coeﬃcient (R) was calculated to assess
linear correlation of each pair’s correlation degree. Mutual information (MI) was determined to
evaluate information shared between cross-modality signals. This is, to the extent of our knowl-
edge, the first report to both qualitatively and quantitatively correlate OCT measurements with
other modern imaging modalities. Results indicate the reported OCT forward imaging method
is an eﬃcient imaging modality for in vivo brain measurement of living animals, and could be
potentially integrated to minimally-invasive neurointervention as guidance.
2. Materials and methods
2.1. OCT signal acquisition
The in vivo optical coherence tomography (OCT) measurements of rat brain were performed
with a fiber-based Spectral-Domain OCT (SDOCT) system utilising a super-luminescent diode
(SLD) with center wavelength at 840 nm as a light source. The measured axial resolution of
the system is 14.5 μm in air. The SDOCT system is connected to an ultra-thin single mode
glass fiber based catheter, of which the outer diameter is 125 μm, enabling minimally invasive
forward imaging within the brain of living animals [9].
In total, ten animals were included in OCT measurements. All animal experiments conducted
in this study were performed with approval from the locally responsible Animal Welfare Com-
mitte with the Regierungspräsidium Freiburg in accordance with the guidelines of the European
Union Directive 2010/63/UE. The animal model chosen consists of adult female Sprague Daw-
ley rats (Charles River, Germany), weighing 280-320 g. The rats were initially anaesthetized by
a cocktail of 100 mg/kg ketamine and 5 mg/kg xylazine, administered by intraperitoneal (i.p.)
injection, and were given acepromazin on the scalp prior to the operation for pain management.
The body temperature was maintained at 37 ◦C by a circulating water-bath heating pad. The
rat was fixed into a stereotactic frame with a pair of ear bars and a bite clip. A burr hole (1
mm) was drilled through the skull by using a cordless handheld microdrill. The dura mater was
removed with fine-tipped tweezers and the pia mater was perforated with a 29 G hypodermic
needle, before the fiber probe was inserted into the brain. Thereby, the dimpling eﬀect in brain
tissue during the probe insertion was minimized [20]. During the experiment, the rat’s anaesthe-
sia status was maintained by giving 30% of the initial anaesthesia dose i.p. when the rat showed
a toe-twitch reflex. Physiological saline and glucose was injected subcutaneously in order to
supplement the body fluid.
The fiber catheter was advanced into the brain along a ventral-dorsal orientated trajectory
stepwisely with an increment of 0.2 mm. At each depth position along the trajectory, an OCT
A-scan signal was recorded for about 30 s. Then the A-scan signal from each depth was plotted
as a function of the forward distance, was averaged and vertically aligned to construct a gray
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Fig. 1. An illustration of trajectory profiles extracted from OCT data, displaying intensity
and attenuation data. (a) A gray scale image of a sample trajectory reconstructed from 51
vertically aligned A-scan signals taken from 51 measuring steps of along this trajectory. (b)
The line profile signal of the OCT image is obtained at the position indicated by a yellow
line in (a). The attenuation factor of brain tissue is calculated from the A-scan signal at
each depth position in the trajectory, (c1) shows the A-scan plot from position at 0.8 mm
(marked by the left green line in (a)). (c2) shows the A-scan plot from position at 9.6 mm
(marked by the right green line in (a)). The red lines in these two A-scan plots demonstrate
the linear fit by which the attenuation factor is extracted. The overall attenuation profile of
the trajectory is shown in (c3).
scale image of this trajectory, shown in Fig. 1(a). Two types of quantitative measures derived
from OCT A-scans were used to correlate with the other image modalities: (i) Trajectory profile
which was taken from the reconstructed OCT image at the horizontal position 0.1 mm ahead
of the probe indicated by a yellow line, shown in Fig. 1(b). This 0.1 mm depth position was
determined empirically as we found that OCT A-scans amplitude reached the maximum value
around this depth in homogeneous optical phantom. (ii) Attenuation coeﬃcient data [Fig. 1(c3)]
of which each data point was extracted from the linear fit of the corresponding A-scan plot
[Figs. 1(c1) and 1c2)] along the trajectory. The penetration depth of brain tissue at the utilized
840 nm light source is around 1 mm [11], thus we applied fitting on 0.3 mm length of A-scan
signal to get the attenuation factor.
2.2. Signal acquisition with MRI and DT-MRI
The magnetic resonance (MR) image acquisition was conducted with a 9.4 T small-bore animal
scanner (Bruker BioSpec 94/20, Ettlingen, Germany) equipped with a BGA12S gradient system
capable of 675 mT/m. For imaging rat brain, a transmit 1H quadrature birdcage resonator with
an inner diameter of 72 mm was used for radio frequency excitation and a 4-channel phased
array head coil was used as a receiver (Bruker BioSpin, Ettlingen, Germany) [21,22] [Fig. 2(c)].
Six from the ten animals that were measured with OCT, were further investigated with MRI
(a)
(b)
(c)
Fig. 2. Experimental setup of animal MRI measurement. (a) A MRI-adapted stereotaxic
frame for fixation and ventilation tubing for anaesthesia. (b) An illustration of animal place-
ment in the frame. (c) This picture shows the RF coil used in the measurement. The red line
indicates the center position of the MR scan.
scan. All animal experiments performed in the MRI study were approved by regional ethic
committee (approval G-13/02), and were in accordance with the guidelines of European Com-
munities Council. Animals, of which the type, age and weight are the same as in the OCT study,
were anaesthetised using an isofluran-oxygen mixture (3% isofluran for induction, 1.6 Vol%
isofluran for maintenance). A MRT-adapted stereotaxic frame was used to fix the animal head,
shown in Figs. 2(a) and 2(b). Heart rate, respiration, and body temperature of the animal were
monitored through the whole measurement. An external heating bath pad was used to maintain
the body temperature at 37 ◦C.
A T2-weighted RARE (Rapid Imaging with Refocused Echoes) sequence was achieved by
consecutively acquiring 45 axial slices of 600 μm thickness in 29 min, which covered the whole
rat brain volume. Brain coronal images were obtained with an in-plane resolution of 90 x 90
μm (matrix 256 x 188 pixel and a field of view FOV = 23 x 17 mm); repetition time (TR)
of 7000 ms, echo time (TE) of 40 ms and a RARE factor of 4, for 4 averages to enhance the
signal-to-noise ratio (SNR). DT-MRI data were acquired in axial 700 μm thickness slices with
the same orientation as for the previous T2-weighted scans, using a 4-shots diﬀusion tensor
echo-planar imaging (DT-EPI) weighting method. In total 40 axial slices were acquired in 99
min to cover the whole rat brain volume. Slices were acquired with a TR of 11250 ms, and a
TE of 24.5 ms. Time (Δ) between the application of diﬀusion gradient pulses, 14 ms; diﬀusion
gradient duration (δ), 4 ms. The acquisition protocol included the use of 30 gradient diﬀusion
directions (Jones 30 encoding scheme), using a b-factor of 1000 s/mm2. Four averages were
used to increase the SNR. The native spatial resolution of the acquired q-space data is 202 x
202 μm at FOV of 23 x 17 mm with an acquisition matrix of 114 x 84 pixel. To explore the
ensemble of living rat brain fiber pathways we adopted a 3D global fiber tracking approach that
processes DTI data [23, 24]. Using the global rat brain fiber tracking data we further computed
high resolution fiber density maps. The source of contrast in presented images is therefore
based on the density of fibers generated during the global tracking optimisation, and passing
the image voxel at specific spatial coordinates. The reconstructed high resolution fiber density
maps (FDMs) have a x-y resolution of 25.2 x 25.3 μm, and were obtained in 87.5 μm slice
thickness. The DTI parameter we used to compare against OCT data (both intensity profile and
attenuation profile) was the intensity profile of the reconstructed FDMs.
2.3. Brain histology
For qualitative correlation, histology were performed to the rats that were examined with
both MRI and OCT. The rat brains were removed right after decapitation, fixed with 4%
paraformaldehyde (PFA) in phosphate-buﬀered saline (PBS). 20 μm thick coronal slices were
obtained and prepared with Nissl staining. The microscopic imaging were captured at a scan-
ning resolution of 4000 dpi by using a histology slide scanner (Nikon Super Coolscan LS 5000
) and Vuescan scanner software.
The rat brain histology images we employed to obtain statistical assessment were taken from
the widely used rat brain atlas [18]. Both cresyl violet and acetylcholinesterase (AChE) stained
histology images were used for the validation. In brief, cresyl violet stains cell core and Nissl
substance in dark violet, while acetylcholinesterase stains axons and cell bodies containing
acetylcholine. The staining protocol were previously described by Paxinos et al. [18]. The image
resolution is about 15.8 μm per pixel.
2.4. Qualitative correlation
OCT intensity profile data and attenuation coeﬃcient data were correlated with the correspond-
ing MRI images and histological microscopic images that were obtained from the same animal.
Brain anatomical structures were identified in the OCT signals by comparing with MRI and
histological images.
2.5. Quantitative correlation
Measured MRI data (T1, T2, and FDM) from one animal were utilised as the standard MRI,
whilst histology images extracted from a published rat brain atlas were employed as the standard
histology data [18]. The standard MRI and histology data were compared with the OCT data
that were obtained from all ten animals. Coronal MRI and histological images, with the same
anterior-posterior (AP) coordinate as OCT data were selected and extracted from the MRI whole
brain image set and the ’rat brain atlas’ sections, respectively [Fig. 3]. Then the intensity profile
of the measuring trajectory where the OCT data was obtained, was extracted from each image
modality. In Fig. 3, the trajectory is indicated by the red line in the image, and its corresponding
profile plot is shown besides. For validation, the profile data from each image modality was
used to correlate with the OCT profile data and attenuation data.
Since the OCT data were acquired with a step size of 0.2 mm yielding a signal length of ap-
proximately 50 data points while the profile signal of FDM or histological images are about of
600 data points, a preprocessing procedure including interpolation of OCT data and resample of
the other profiles (FDM, histological images) was implemented to compensate the undesirable
large diﬀerence in data length. We chose spline interpolation which uses low-degree polyno-
mials in each of the intervals to increase OCT signal data points to five times more than the
original signal, resulting a signals length of about 300. Then a resampling process was applied
to MRI and histological signals to equalise the length of the profile signals.
2.5.1. Dynamic time warping
The consolidated signals, of which the length was equalized and the amplitude was normalized,
were then warped and aligned by applying dynamic time warping (DTW). DTW determines the
similarity of two time sequences which share some common waveform patterns though having
diﬀerent duration. It calculates the optimal alignment between two time series by identifying the
optimal warping path in the distance matrix calculated under certain constrains [25–27]. DTW
was used to determine the cost of aligning OCT signal with the line profile signal extracted
from other imaging modalities (T1 and T2-weighted MR images, fiber density maps, histology
images) for three purposes: (i) correcting distortions in the OCT data acquisition due to the
Fig. 3. A collage of selected images from MRI measurement and histological staining,
and the profile data from trajectories indicated with the red line. All images (T1-weighted
(a), T2-weighted (b), DTI fiber density map (c), cresyl violet staining (e), and acetyl-
cholinesterase staining (f)) are with the same anterior-posterior coordinate Bregma - 2.00
mm, trajectories are located at medial-lateral - 2.50 mm. Panel (d) is the atlas sketch illus-
trating the anatomic structures lying on the trajectory path.
uniformity of the fiber translation, (ii) correcting distortions in the histological preparation due
to the fact that the dehydration and fixation processes could deform the brain structures.
2.5.2. Correlation coefficient
For each compared signal pair, we employed Pearson’s correlation coeﬃcient to estimate the
degree of linear dependency (correlation degree, R) between the two samples [15, 28, 29]. The
absolute value of the sample correlation coeﬃcient R (R ≤ 1) of each signal pair was calculated
in Matlab. Box plot (Spear style) was used to depict the statistic distribution of the determined
correlation coeﬃcient of the paired signal from six representative trajectories [30].
2.5.3. Mutual information
Mutual information (MI) is an entropy based measure that determines the statistical dependancy
between two random variables [31]. It has been implemented in cross-modality image registra-
tion by determining the joint histogram of two images [32]. Because the nature of the image
intensities and the relationship between the grey-values in the diﬀerent modalities do not play
an role in the MI conducted correlation, MI is thus a robust and eﬃcient method to compare
signals from two diﬀerent imaging modalities which present in our study. The mutual informa-
tion I (A, B) of two variables, A and B, is related to entropy and is calculated by the following
equation
I (A, B) = H (A) + H (B) − H (A, B) (1)
where H (A) and H (B) are the entropy of A and B, respectively. H (A, B) is the joint entropy
of A and B. The higher MI value means that the compared two variables are more statistically
dependant. In this study, MI of two signals from their respective imaging modality is determined
without applying DTW to the signals.
3. Results
3.1. Qualitative correlation
The OCT intensity profile and attenuation coeﬃcient data were compared with T2-weighted
MR images and histological images with respect to the identified anatomical structures. Two
representative illustrations of the correlation of anatomical structures are shown in Fig. 4. Two
dimensional grayscale OCT images were reconstructed from the sequentially acquired A-scans
during translating the OCT fiber probe along a trajectory into brain, shown in Figs. 4 (a4) left
and (b4) left. Both of the OCT intensity profiles and the attenuation signals presented promi-
nent peak values corresponding to corpus callosum, superior colliculus, optic tracts, as well as
cerebral peduncle which all belong to brain white matter that basically compose of neural fibers
(indicated by black dotted lines). These structures revealed in OCT signals were also distin-
guishable in MRI and histological images. Interestingly, a high contrast in hippocampus region
was only revealed in OCT attenuation signals, tentatively caused by the backscattering from
multiple hippocampal layers.
3.2. Quantitative correlation of the compared signal pairs
In this study, we evaluated in vivo OCT measurement of rat brain by correlating the attenua-
tion factor and intensity profiles extracted from OCT measurements on the same trajectory with
profiles from T1 and T2-weighted MR images, FDM, and histological images. In total, there
were 10 types of signal pairs analysed in this work, which are T1, T2, FDM, cresyl violet, and
AChE correlated with OCT profile data or OCT attenuation data, respectively. We investigated
the correlation degree of signal pairs from six diﬀerent trajectories: AP - 5.40 mm, ML - 2.00
mm; AP - 4.70 mm, ML - 3.00 mm; AP - 4.20 mm, ML - 2.60 mm; AP - 3.50 mm, ML - 2.80
mm; AP - 2.00 mm, ML - 2.50 mm; AP - 1.00 mm, ML - 3.00 mm (all AP positions were
referred to Bregma). Raw image profiles of two representative brain trajectories are shown in
Fig. 5, of which the signal length is unequal due to diﬀerent sampling rate or spatial resolution
of respective imaging modalities. In order to align and compare signals from various imaging
modalities, we applied resampling to equalize the signal length and normalization to unify the
signal amplitude. The consolidated data are aligned and shown in Fig. 6. We found in trajectory
A, the OCT signals presented two prominent peaks locating at trajectory depth of 2.3 mm and
3.9 mm respectively, where the anatomical structures corpus callosum and superior colliculus
are. These two structures were also notably revealed in T1, FDM and AchE profiles, demon-
strating resemblances between OCT signals and these image profiles, indicated by arrows in
Figs. 6(a) and 6(b). Similarly, in trajectory B correspondences were identified in several depth
positions across diﬀerent image modalities which are indicated by arrows in Figs. 6(c) and 6(d).
By Dynamic Time Warping (DTW), a distance matrix is generated by calculating the distance
from every data point in one signal to each data point in the other signal. The normalized
warping distance (WD) is a measure to estimate the cost of aligning two signals, and thus is
adopted in thus study to compare signals. The larger the warping distance is, the more diﬃcult
Fig. 4. Two representative illustrations of correlation of anatomical structures between OCT
signals, T2-weighted MR image, fiber density map and histology image are shown here.
The black dotted lines indicate various identified anatomical structures, and show the agree-
ment between image modalities. Both of the OCT intensity profiles and the attenuation
present prominent hyperreflective bands corresponding to corpus callosum, superior col-
liculus, optic tracts, and as well as cerebral peduncle which are brain white matter basically
compose of neural fibers. These structures revealed in OCT images and signals are also
distinguishable in MRI and histological images. x, and y axis of OCT images in a4 and b4
denote look ahead distance (mm) and trajectory depth (mm), respectively.
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Fig. 5. A collage of OCT data, MRI profiles, and histological profile signals of two sample
trajectories. Left panels show the location of trajectories illustrated by the red line in the
rat atlas schematics. The coordinate of trajectory A is AP - 2.00 mm, ML - 2.50 mm (a),
trajectory B is AP - 5.40 mm, ML - 2.00 mm (b). The plots in right panels are OCT atten-
uation profile, OCT intensity profile, T1 T2 FDM profile, and histological profile of each
trajectory respectively.
it is to warp and align two signals which consequently means that the more distortions of the two
signals are corrected. For all six trajectories, we calculated the WD of each compared signal pair
and displayed them with box plot shown in Figs. 7(a) and 7(b). Among OCT attenuation data
pairs, OCT vs.T2 owned the largest mean WD 17.08 (averaged from 6 trajectories), whereas
OCT vs. DTI-FDM had the least mean value of the WD 5.28. OCT vs. T2 had a strong divergent
distribution of the WD value, while the WD value of OCT-AChE pair was centralised [Fig. 7(a)].
Among the WD of the OCT profile data pairs, OCT-T2 had the largest WD value of 12.82, while
OCT-AChE had the lowest WD value of 5.53 [Fig. 7(b)]. In addition, both OCT-T1 and OCT-T2
featured more a divergent distribution compared with the other signal pairs .
We calculated the correlation coeﬃcient (R) and the mutual information (MI) of the ten
signal pairs without applying the DTW process, and presented their distribution with box plot
in Figs. 7(c) - 7(f). The R value of all compared signal pairs were lower than 0.5, with 90% of
the median R value were lower than 0.2. This finding indicates the OCT signals are not linearly
correlated to other modalities under the validation method of correlation coeﬃcient. While the
mutual information of OCT against MRI, including both T1-weighted and T2-weighted images,
were markedly greater than the other signal pairs, as shown in Figs. 7(e) and 7(f).
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4. Discussion
4.1. Correlation ratios
In this study, we aimed to give both qualitative and quantitative evaluation of in vivo OCT
measurement of rat brain by correlating the OCT measurement with other image modalities,
such as MRI images and histological images. To accomplish the quantitative evaluation for
each measured brain trajectory we extracted two quantitative signals from OCT measurements:
(i) tissue attenuation factor as a function of the trajectory depth, (ii) profile of the reconstructed
OCT grayscale intensities along the trajectory. Warping distance (WD) elicited from dynamic
time warping, correlation coeﬃcient (R) and mutual information (MI), were the measures se-
lected in this study to estimate the correlation ratios of two compared cross-modality signals.
OCT versus MRI
When correlating the OCT attenuation profile with the profile data of T1 and T2-weighted MR
images, it required more computing cost (larger warping distance) obtain an optimal alignment
in the DTW process. In addition, the compared signal pairs also had low correlation coeﬃcient
values meaning they have weakly linear correlation. This is presumably induced by the diﬀer-
ence in the essential imaging principle of OCT and MRI. In MRI, the contrast between tissue
types is based on the diﬀerences in the spin relaxation rate and density of hydrogen atoms.
T1 and T2 decay constants are fundamental properties of biological tissue containing water
molecules. In brain tissue, cerebrospinal fluid (CSF) has the longest T1 and T2, gray matter has
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Fig. 7. The upper two figures are warping distance distribution depicted with box plot.
The middle and lower rows of figures are the distribution of correlation coeﬃcient (R) and
mutual information (MI) of the compared signal pairs before warping process, respectively.
a median T1 and T2, and white matter has the shortest time [33]. The signal intensity of each
tissue type in MRI images eminently corresponds to its relaxation time and hydrogen density.
Compared with optical properties, the ratio of these values do not strongly change in subclasses
of anatomical structures, like the thalamus and cortex. This yields to a low contrast in MRI
between gray matter structures [34, 35]. However, among the five diﬀerent imaging modalities
we used to compare with OCT measurements, the mutual information of MRI versus OCT were
markedly higher than the others. Presumably, this results from a lower joint entropy meaning
there are more shared information within these two modalities irrespective to linear relation.
OCT versus fiber density maps (FDM)
The contrast within fiber density map (FDM), which is derived from DTI and fiber tractography,
represents the best estimation of the degree of the water molecule’s diﬀusion at that position
presumably along fibrous structures. In neuroimaging, DTI is often employed to depict white
matter tracts and thus brain connectivity with mapping of the axonal connections. Whereas,
the lipid-rich myelin sheaths of axons or axons bundles feature with a high scattering property
which thus gives high backscattering intensity in OCT signals [36]. Although we expected the
OCT and fiber density map which is derived from the DTI acquisition may feature the highest
correlation since they have very similar origin of contrast, the three diﬀerent statistical corre-
lation measures we estimated did not present any significant higher correlations than the other
modalities. Nevertheless, resemblances and overlaps which are corresponding to some identified
anatomical structures including corpus callosum, superior colliculus and etc., were determined
between OCT and FDM profile signals and are shown in Fig. 6.
OCT versus histology
In other studies, OCT cross-sectional images are often evaluated by comparing with the cor-
responding histology images [37]. Here, we assessed the OCT A-scan signals with the corre-
sponding histological profile signals. In cresyl violet staining, cell core and Nissl substance
appear in dark violet colour, whereas cytoplasm and the rest substance appear in light violet or
light blue [38]. Thus, the brain region where cell density is higher such as cortex and dentate
gyrus layer in hippocampus, features a low gray scale intensity value in the profile signal. On
the contrary, white matter consists of lipid-rich myelinated fibers has a high gray scale inten-
sity value. AChE staining is used to determine the distribution of acetylcholinesterase (AChE)
in brain sections, the intensity of which is an indication of the quantity of the enzyme present
which correspond to the distribution of the neurotransmitter acetylcholine (ACh) [38,39]. Axon
fiber possessing low quantity of ACh has extremely high gray scale intensity in the profile sig-
nal, while gray matter containing predominantly neuron cell bodies appears darker in the image
featuring low intensity value of the profile signal. Noticeably, AchE better correlates to OCT
signal featuring a higher correlation coeﬃcient and mutual information, compared to c-violet
staining.
4.2. Methodology and limitations
In neurosurgery, minimally-invasive intervention is much appreciated as it leads to minimal tis-
sue disruptions and less complications compared to open craniotomy [40,41]. Such a procedure
is often adopted in deep brain stimulation [42] and epilepsy surgery [43], where recording micro-
electrodes are implanted into deep brain structures. Fiber-based endoscopic imaging modalities,
including optical coherence tomography [9], optical diﬀuse reflectance spectroscopy [44] and
others, have been developed to guide the implantation. The guidance is realized by identifying
tissue type in the vicinity of the electrode for localization, and most crucially by visualizing
tissue ahead of the electrode to avoid penetrating any critical structures such as major vessels.
To facilitate in vivo OCT measurement of deep brain structures, a particularly thin fiber probe,
which can be easily fitted into the working channel of any existing neuronavigation tools or/and
integrated with the electrode, is desired. We are aware that a rotating probe utilized in intracoro-
nary OCT could provide informative cross-sectional images of the surrounding tissue, however
for the specific neurosurgery guidance forward imaging modality is still preferred as it reveals
particularly what is ahead of the probe. As such, there is certainly a need to evaluate the 1-D
OCT measurement from forward scanning and compare to the other imaging modality.
We are aware that there are various factors which could aﬀect the quantification such as the
focal length and sensitivity variations with wavelength [45, 46]. The quantitative tissue attenua-
tion coeﬃcient can be estimated to characterize tissue types when OCT A-scans are calibrated
with known reflectance from a glass/air interface and corrected with uniform diﬀuse-scattering
media [47, 48]. In our work, A-scan amplitude was calibrated and normalized to a glass/air
interface, however it was not corrected with a homogeneous optical phantom. Thus we are
fully conscious that the attenuation coeﬃcient we extracted from OCT A-scans are not directly
comparable with measurements from other systems. Nevertheless, the tissue attenuation factors
(instead of using the term of "attenuation coeﬃcient") we determined are able to diﬀerentiate
brain tissue types in this study.
Contrast in OCT data sets originates in tissue’s optical scattering properties at the illuminat-
ing wavelength. Therefore, the OCT attenuation profile reflects the tissue attenuation coeﬃcient
(sum of scattering coeﬃcient and absorption coeﬃcient) distribution along the trajectory, whilst
the OCT intensity profile reveals the tissue reflectivity (backscattering property) along the tra-
jectory. Aim of this study was to take a step towards a better understanding of the OCT contrast
in vivo. However, it goes far beyond the scope of this study to take diﬀerences in optical prop-
erties on a cellular scale, like geometrical features as structures perpendicular to the light path
as opposed to parallel paths, round fibers vs. ill-defined somata, as well as specific optical prop-
erties, like dichroic myelin sheaths as opposed to simple neuron membranes, to name a few,
into account. Still, above mentioned measurements enabled us to conservatively compare OCT
contrast to other imaging modalities.
5. Conclusion
In this study we report, to our best knowledge, the first quantitative evaluation of the in vivo
OCT measurement of rat brain by correlating them with the corresponding MRI signals and
histological signals. We evaluated in total ten signal pairs which were OCT attenuation profile
versus T1 and T2-weighted MR images, fiber density maps (FDM), Histo-AChE, and Histo-
CViolet respectively, and OCT intensity profile versus T1 and T2-weighted MR images, fiber
density maps, Histo-AChE, and Histo-CViolet respectively. We estimated the degree of the cor-
relation of the compared signal pair by determining warping distance (WD), statistics correla-
tion coeﬃcient (R) and mutual information (MI). We found that the OCT measurements shared
more information with MRI images with notably higher mutual information values. The OCT
measurements had relevant correlation with both AChE and cresyl violet staining. Since the con-
trast in all three well correlating imaging modalities (FDM, CV and AChE) is based on fibrous,
little cell containing structures, we primarily conclude, that OCT image contrast in brain is
strongly linked to the appearance of the very same fibrous, well ordered and myelin-rich struc-
tures. This quantitatively supported conclusion backs up our previously proposed minimally
invasive, endoscopic in vivo brain imaging method [9], but casts doubt on the usability of OCT
to online monitor gliotic ensheathing of brain implants [11].
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